Biomedical Engineering Reference
In-Depth Information
114. Shively, J.E. and Conrad, H.E., Nearest neighbor analysis of heparin: Identifi cation and quantitation of
the products formed by selective depolymerization procedures,
Biochemistry
, 15, 3943, 1976.
115. Robinson, H.C. et al., A proteoglycan form of heparin and its degradation to single-chain molecules,
J. Biol. Chem
., 253, 6687, 1978.
116. Iacomini, M. et al., “Linkage Region” sequences of heparins and heparan sulfates: Detection and quan-
tifi cation by nuclear magnetic resonance spectroscopy,
Anal. Biochem
., 274, 50, 1999.
117. Lindahl, U. and Axelsson, O., Identifi cation of iduronic acid as the major sulfated uronic acid of hepa-
rin,
J. Biol. Chem
., 246, 74, 1971.
118. Riesenfeld, J., Hook, M., and Lindahl, U., Biosynthesis of heparin. Assay and properties of the micro-
somal N-acetyl-D-glucosaminyl-N-deacetylase,
J. Biol. Chem
., 255, 922, 1980.
119. Jacobsson, I. et al., Biosynthesis of heparin. Substrate specifi city of heparosan N-sulfate D-glucuronosyl
5-epimerase,
J. Biol. Chem
., 259, 1056, 1984.
120. Miller, R.R. and Waechter, C.J., Partial purifi cation and characterization of detergent-solubilized
N-sulfotransferase activity associated with calf brain microsomes,
J. Neurochem
., 51, 87, 1988.
121. Lind, T., Lindahl, U., and Lidholt, K., Biosynthesis of heparin/heparan sulfate. Identifi cation of a 0-kDa
protein catalyzing both the D-glucuronosyl- and the N-acetyl-D-glucosaminyltransferase reactions,
J. Biol. Chem
., 268, 20705, 1993.
122. Lidholt, K. and Lindahl, U., Biosynthesis of heparin. The D-glucuronosyl- and N-acetyl-D-glucosami-
nyltransferase reactions and their relation to polymer modifi cation,
Biochem. J
., 287, 21, 1992.
123. Jacobsson, I. and Lindahl, U., Biosynthesis of heparin. Concerted action of late polymer-modifi cation
reactions,
J. Biol. Chem
., 255, 5094, 1980.
124. Foster, A.B. et al., Amino-sugars and related compounds. Part IX. Periodate oxidation of heparin and
some related substances,
J. Am. Chem. Soc
., 85, 2279, 1963.
125. Lidholt, K., Kjellen, L., and Lindahl, U., Biosynthesis of heparin. Relationship between the polymeriza-
tion and sulphation processes,
Biochem. J
., 261, 999, 1989.
126. Toma, L., Berninsome, P., and Hirschberg, C.B., The putative heparin specifi c N-acetylglucosaminyl
N-deacetylase/N-sulfotransferase also occurs in non-heparin-producing cells,
J. Biol. Chem
., 273,
22458, 1998.
127. Ogren, S. and Lindahl, U., Cleavage of macromolecular heparin by an enzyme from mouse mastocy-
toma,
J. Biol. Chem
., 250, 2690, 1975.
128. Ogren, S. and Lindahl, U., Metabolism of macromolecular heparin in mouse neoplastic mast cells,
Biochem. J
., 154, 605, 1976.
129. Fareed, J. et al., Pharmacokinetics of low molecular weight heparins in animal models,
Semin. Thromb.
Hemost
., 25, 51, 1999.
130. Fareed, J., Haas, S., and Sasahar, A., Past, present and future considerations on low molecular weight
heparin differentiation: An epilogue,
Semin. Thromb. Hemost
., 25, 145, 1999.
131. Jaikaria, N.S. et al., Interaction of fi bronectin with heparin in model extracellular matrices: Role of
arginine residues and sulfate groups,
Biochemistry
, 30, 1538, 1991.
132. Zak-Nejmark, T. et al., Heparin modulates migration of human peripheral blood mononuclear cells and
neutrophils,
Arch. Immunol. Ther. Exp. (Warsz)
, 47, 245, 1999.
133. Jeske, W. and Fareed, J., Antithrombin III-and heparin cofactor II-mediated anticoagulant and antipro-
tease actions of heparin and its synthetic analogues,
Semin. Thromb. Hemost
., 19, 241, 1993.
134. Rosenfeld, R.D., Role of heparin and heparin-like molecules in thrombosis and athersclerosis,
Fed.
Proc
., 44, 404, 1985.
135. Frebelius, S., Hedin, U., and Swedenborg, J., Thrombogenecity of the injured vessel wall—role of anti-
thrombin and heparin,
Thromb. Haemost
., 71, 147, 1994.
136. Barrowcliffe, T.W. et al., The anticoagulant activity of heparin: Measurement and relationship to chemi-
cal structure,
J. Pharm. Biomed. Anal
., 7, 217, 1989.
137. Liu, L. et al., Inhibition of thrombin by antithrombin III and heparin cofactor II
in vivo
,
Thromb.
Haemost
., 73, 405, 1995.
138. Wu, Y.I., Sheffi eld, W.P., and Blajchman, M., Defi ning the heparin-binding domain of antithrombin,
Blood Coag. Fibrinol
., 5, 83, 1994.
139. Horner, A.A. and Young, E., Asymmetric distribution of sites with high affi nity for antithrombin III in
rat skin heparin proteoglycans,
J. Biol. Chem
., 257, 8749, 1982.
140. Jacobsson, K.-G., Lindahl, U., and Horner, A.A., Location of antithrombin-binding regions in rat skin
heparin proteoglycans,
Biochem. J
., 240, 625, 1986.
